GHRL and chronic obstructive pulmonary disease: This substudy of a multicenter, randomized, double-blind, placebo-controlled trial of ghrelin treatment in underweight COPD patients was designed and powered to investigate the effects of repeated ghrelin administration and the underlying mechanisms using cardiopulmonary exercise testing.